Study Information
| Title: | Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer  |
| Status: | Recruiting participants |
| Conditions: | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
| Interventions: | Biological: bevacizumab; Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel |
| Institutions: | Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, Tufts Medical Center, Baystate Medical Center, Lahey Clinic Medical Center |
| Health Topics: | Fallopian Tube Cancer, Ovarian Cancer |
Contact Information
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, MA 01199
Tashanna K.N. Myers
413-794-9338
Beth Israel Deaconess Medical Center
Boston, MA 02215
Clinical Trials Office - Beth Israel Deaconess Medical Center
617-667-9925
Dana-Farber/Brigham and Women's Cancer Center
Boston, MA 02115
Clinical Trials Office
617-724-5200
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, MA 02115
Carolyn N. Krasner
617-632-3474
Lahey Clinic Medical Center - Burlington
Burlington, MA 01805
Clinical Trials Office - Lahey Clinic Medical Center - Burling
781-744-8027
Massachusetts General Hospital
Boston, MA 02114
Clinical Trials Office - Massachusetts General Hospital
877-726-5130
Tufts Medical Center Cancer Center
Boston, MA 02111
Michael G. Kelly
617-636-6100